The Santa Fe Institute’s Board of Trustees has welcomed two new members. Remi Barbier of Pain Therapeutics, Inc. and Andrew Feldstein of BlueMountain Capital Management were elected to the Board at the Institute's Annual Business Network and Trustees Symposium in November.

"We are delighted to welcome these bright and accomplished new members to our board," said SFI Chairman Michael Mauboussin. "Andrew and Remi have shown exemplary leadership, initiative, and insight in their professional careers. Their guidance will no doubt contribute to the SFI’s future success as a leading research institute for complexity science."

Remi Barbier is founder, Chairman, and CEO of Pain Therapeutics, Inc., a firm developing novel drugs in the areas of pain management and oncology that he founded in 1998. Previously, Mr. Barbier helped in the founding and/or growth of: Exelixis Inc., a functional genomics company; ArQule, a chemistry company; and EnzyMed (now owned by Albany Molecular Research), a chemistry company. Mr. Barbier served as the Chief Operating Officer of Exelixis from January 1996 to May 1998. He served as Vice President of Corporate Development and Clinical Project Manager of Xoma Corporation, a biotechnology company from October 1993 to December 1995. Mr. Barbier serves as a Director of Mendel Biotechnology, Inc. and of Poetic Genetics, Inc. He holds a BA from Oberlin College and an MBA from the University of Chicago. He is a trustee of the Carnegie Institute of Washington and on the Advisory Board of the California Institute for Quantitative Biosciences.

Andrew Feldstein is the CEO and Co-CIO of BlueMountain Capital Management. Mr. Feldstein is the Chair of the Firm’s Management Committee and a member of the Investment and Risk Committees. Prior to co-founding BlueMountain in 2003, Mr. Feldstein spent over a decade at J.P. Morgan where he was a Managing Director and served as Head of Structured Credit; Head of High Yield Sales, Trading and Research; and Head of Global Credit Portfolio. Mr. Feldstein is a member of the board of directors of PNC Financial Services Group Inc. He is also a Trustee of Third Way, a prominent, centrist think tank and a member of the Harvard Law School Leadership Council. Mr. Feldstein holds a J.D. from Harvard Law School and a B.A. from Georgetown University.

SFI's Board also bid farewell to three longstanding trustees. Dan Lynch, Henry Lichstein, and Stewart Greenfield retired from the board, with SFI’s gratitude for their excellent contributions.

The Santa Fe Institute’s Board of Trustees, which has the fiduciary responsibility for the Institute, oversees SFI’s operations through its biannual meetings and its active committees that offer advice and support to SFI’s leadership.

More SFI News